BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23202951)

  • 1. Over-expression of semaphorin4D, hypoxia-inducible factor-1α and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer.
    Chen Y; Zhang L; Pan Y; Ren X; Hao Q
    Int J Mol Sci; 2012 Oct; 13(10):13264-74. PubMed ID: 23202951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Wang K
    Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
    Chen Y; Zhang L; Lv R; Zhang WQ
    Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1α and semaphorin4D genes involved with tumor-associated macrophage-induced metastatic behavior and clinical significance in colon cancer.
    Mu L; Wang J; Chen Y; Li L; Guo X; Zheng S; Jing C
    Chin Med J (Engl); 2014; 127(20):3568-75. PubMed ID: 25316231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
    Yu L; Wu SW; Zhou L; Song WQ
    Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
    Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
    Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
    Wang M; He Y; Shi L; Shi C
    Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
    Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
    Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer.
    Shen W; Li HL; Liu L; Cheng JX
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AEG-1 Contributes to Metastasis in Hypoxia-Related Ovarian Cancer by Modulating the HIF-1alpha/NF-kappaB/VEGF Pathway.
    Yu X; Wang Y; Qiu H; Song H; Feng D; Jiang Y; Deng S; Meng H; Geng J
    Biomed Res Int; 2018; 2018():3145689. PubMed ID: 29770329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y; Xu Y; Ma J; Pang X; Dong M
    Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Angiogenesis in the Persistence of Chemoresistance in Epithelial Ovarian Cancer.
    Nusrat O; Belotte J; Fletcher NM; Memaj I; Saed MG; Diamond MP; Saed GM
    Reprod Sci; 2016 Nov; 23(11):1484-1492. PubMed ID: 27122375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation and clinical significance of expressions of HIF-1α and Sema4D in colorectal carcinoma tissues].
    Mu L; Wang J; Guo X; Zheng S; Shan K; Jing C; Li L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):388-92. PubMed ID: 24760652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological and prognostic significance of hypoxia-inducible factor 1α expression in epithelial ovarian cancer: a meta-analysis.
    Jin Y; Wang H; Liang X; Ma J; Wang Y
    Tumour Biol; 2014 Aug; 35(8):8149-59. PubMed ID: 24845029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer.
    Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G
    Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX; Luo M; Qiu LW; He YL; Wang XF
    Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition.
    Zhang L; Chen Y; Li F; Bao L; Liu W
    Front Immunol; 2019; 10():867. PubMed ID: 31105696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
    Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
    Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.